Scale-up of Adhesive Transdermal Drug Delivery Systems
dc.contributor.author | Gotto, Amanda | en_US |
dc.contributor.author | Foster, Thomas | en_US |
dc.contributor.author | Shah, Vinod P. | en_US |
dc.contributor.author | Govil, Sharad | en_US |
dc.contributor.author | Gray, Vivian A. | en_US |
dc.contributor.author | Llanos, Hector | en_US |
dc.contributor.author | Hussain, Ajaz S. | en_US |
dc.contributor.author | Hoiberg, Charles | en_US |
dc.contributor.author | Karp, Carol | en_US |
dc.contributor.author | Harder, Samuel | en_US |
dc.contributor.author | Zerbe, Horst | en_US |
dc.contributor.author | Barrett, Colin | en_US |
dc.contributor.author | Gochnour, Scott | en_US |
dc.contributor.author | Swanson, David | en_US |
dc.contributor.author | Van Buskirk, Glenn A. | en_US |
dc.contributor.author | González, Mario A. | en_US |
dc.contributor.author | Cleary, Gary | en_US |
dc.contributor.author | Gale, Robert | en_US |
dc.contributor.author | Berge, Stephen | en_US |
dc.contributor.author | Chan, Keith | en_US |
dc.contributor.author | Flynn, Gordon L. | en_US |
dc.contributor.author | Garrison, Raymond | en_US |
dc.contributor.author | Noonan, Patrick K. | en_US |
dc.contributor.author | Mantelle, Juan | en_US |
dc.contributor.author | Hammar, James | en_US |
dc.contributor.author | Barnhardt, Scott | en_US |
dc.date.accessioned | 2006-09-08T19:16:48Z | |
dc.date.available | 2006-09-08T19:16:48Z | |
dc.date.issued | 1997-07 | en_US |
dc.identifier.citation | Van Buskirk, Glenn A.; González, Mario A.; Shah, Vinod P.; Barnhardt, Scott; Barrett, Colin; Berge, Stephen; Cleary, Gary; Chan, Keith; Flynn, Gordon; Foster, Thomas; Gale, Robert; Garrison, Raymond; Gochnour, Scott; Gotto, Amanda; Govil, Sharad; Gray, Vivian A.; Hammar, James; Harder, Samuel; Hoiberg, Charles; Hussain, Ajaz; Karp, Carol; Llanos, Hector; Mantelle, Juan; Noonan, Patrick; Swanson, David; Zerbe, Horst; (1997). "Scale-up of Adhesive Transdermal Drug Delivery Systems." Pharmaceutical Research 14(7): 848-852. <http://hdl.handle.net/2027.42/41458> | en_US |
dc.identifier.issn | 1573-904X | en_US |
dc.identifier.issn | 0724-8741 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/41458 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9244139&dopt=citation | en_US |
dc.format.extent | 349856 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Kluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Media | en_US |
dc.subject.other | Biomedicine | en_US |
dc.subject.other | Post Approval Changes | en_US |
dc.subject.other | Adhesive Transdermal Systems | en_US |
dc.subject.other | Biomedical Engineering | en_US |
dc.subject.other | Medical Law | en_US |
dc.subject.other | Pharmacology/Toxicology | en_US |
dc.subject.other | Pharmacy | en_US |
dc.subject.other | SUPAC | en_US |
dc.subject.other | Scale-up | en_US |
dc.subject.other | Biochemistry, General | en_US |
dc.title | Scale-up of Adhesive Transdermal Drug Delivery Systems | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | Lohmann Therapeutic Systems, West Caldwell, New Jersey | en_US |
dc.contributor.affiliationother | Novartis Pharmaceuticals Corp., 59 Route 10, East Hanover, New Jersey, 07936 | en_US |
dc.contributor.affiliationother | University of Maryland, Baltimore, Maryland | en_US |
dc.contributor.affiliationother | 3M Pharmaceuticals, St. Paul, Minnesota | en_US |
dc.contributor.affiliationother | Elan Corporation, Athlone, Ireland | en_US |
dc.contributor.affiliationother | Center of Drug Evaluation & Research, FDA, Rockville, Maryland | en_US |
dc.contributor.affiliationother | 3M Pharmaceuticals, St. Paul, Minnesota | en_US |
dc.contributor.affiliationother | Center of Drug Evaluation & Research, FDA, Rockville, Maryland | en_US |
dc.contributor.affiliationother | Cygnus Inc., Redwood City, California | en_US |
dc.contributor.affiliationother | 3M Pharmaceuticals, St. Paul, Minnesota | en_US |
dc.contributor.affiliationother | Noven Pharmaceuticals, Miami, Florida | en_US |
dc.contributor.affiliationother | Schering Laboratories, Miami Lakes, Florida | en_US |
dc.contributor.affiliationother | Pharmaco International, Richmond, Virginia | en_US |
dc.contributor.affiliationother | Center of Drug Evaluation & Research, FDA, Rockville, Maryland | en_US |
dc.contributor.affiliationother | Hercon Laboratory Corp., Emigsville, Pennsylvania | en_US |
dc.contributor.affiliationother | Novartis Pharmaceuticals Corp., Suffern, New York | en_US |
dc.contributor.affiliationother | Bertek, Inc., St. Albans, Vermont | en_US |
dc.contributor.affiliationother | Cygnus Inc., Redwood City, California | en_US |
dc.contributor.affiliationother | Novartis Pharmaceuticals Corp., Suffern, New York | en_US |
dc.contributor.affiliationother | Theratec, Inc, Salt Lake City, Utah | en_US |
dc.contributor.affiliationother | Alza Corp., Palo Alto, California | en_US |
dc.contributor.affiliationother | P'Kinetics, Inc., Miami, Florida | en_US |
dc.contributor.affiliationother | University of Kentucky, Lexington, Kentucky | en_US |
dc.contributor.affiliationother | Alza Corp., Palo Alto, California | en_US |
dc.contributor.affiliationother | USP, Rockville, Maryland | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 9244139 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/41458/1/11095_2004_Article_304228.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1023/A:1012135430056 | en_US |
dc.identifier.source | Pharmaceutical Research | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.